Update shared on 27 Nov 2025
Fair value Increased 3.00%Analysts have raised their price target for Fortis Healthcare from ₹1,023.56 to ₹1,054.25. This change reflects modest improvements in projected revenue growth, even though the outlook for profit margin is slightly lower.
What's in the News
- Northern Tk Venture Pte Ltd completed the acquisition of a stake in Fortis Healthcare Limited for INR 0.3 million on November 4, 2025. (M&A Transaction Closings)
- The Board of Directors has scheduled a meeting on November 11, 2025, to consider and approve the Un-Audited Financial Results for the quarter and half year ended September 30, 2025. (Board Meeting)
- A Special/Extraordinary Shareholders Meeting will be held via Postal Ballot in India on November 15, 2025, to consider the appointment of Dr. Keith Hsiu Chin Lim as a Non-Independent and Non-Executive Director of the Company. (Shareholders Meeting)
- Fortis Healthcare Limited is evaluating legal options following multiple court interventions that impact the planned acquisition and open offer by Northern Tk Venture Pte Ltd and IHH Healthcare Berhad. (M&A Transaction Closings)
Valuation Changes
- Consensus Analyst Price Target has risen slightly, from ₹1,023.56 to ₹1,054.25.
- Discount Rate remains unchanged at 12.76%.
- Revenue Growth has increased marginally, moving from 16.31% to 16.54%.
- Net Profit Margin has decreased slightly, from 15.97% to 15.63%.
- Future P/E ratio has increased, rising from 52.62x to 54.84x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.